Bayer AG· @Bayer · X·· 2026-05-06AI 评分42
AI 导读
#News：我们拟收购 Perfuse Therapeutics，这是一家专注于缺血性眼病的生物制药公司。此次收购补充了我们的制药管线，并强化了我们为患者开发急需疗法的承诺：https://www.bayer.com/media/en-us/
正文
#News: We intend to acquire Perfuse Therapeutics, a biopharmaceutical company focused on ischemia-induced ocular diseases. Acquisition complements our pharmaceutical pipeline & reinforces our commitment to developing urgently needed therapies for patients: https://www.bayer.com/media/en-us/
来源：Bayer AG · x.com